News | November 02, 2025
Dabur India reports consolidated Q2 FY26 PAT at Rs. 452.55 Cr
Dabur India has reported total income of Rs. 3,331.45 crore during the period ended September 30, 2025
Dabur India has reported total income of Rs. 3,331.45 crore during the period ended September 30, 2025
Dr Agarwals Eye Hospital has reported total income of Rs. 118.40 crore during the period ended September 30, 2025
_256_384.jpg)
Cipla has reported total income of Rs. 7,858.39 crore during the period ended September 30, 2025
Tatva Chintan Pharma Chem has reported total income of Rs. 124.52 crore during the period ended September 30, 2025
Indraprastha Medical Corporation has reported total income of Rs. 388.40 crore during the period ended September 30, 2025
Medplus Health Services has reported total income of Rs. 1,696.79 crore during the period ended September 30, 2025
Cobenfy generated $43 million in third-quarter sales, up from $35 million in the second quarter
Novartis India has reported total income of Rs. 99.73 crore during the period ended September 30, 2025
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Dr Reddys Laboratories has reported total income of Rs. 8,805.1 crore during the period ended September 30, 2025
Subscribe To Our Newsletter & Stay Updated
